Yang et al. [40] constructed a prognostic model based on disulfidptosis-associated genes in hepatocellular carcinoma and revealed that the signature was correlated with immunotherapeutic target genes (SLC7A11 and SLC3A2). The gene discussed is SLC3A2; the disease is hepatocellular carcinoma.